Q32 Bio, Inc. (QTTB)
5.86
+0.14
(+2.45%)
USD |
NASDAQ |
Apr 17, 16:00
5.86
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Total Liabilities (Quarterly) : 19.76M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 190.57M |
| Armata Pharmaceuticals, Inc. | 304.78M |
| Artelo Biosciences, Inc. | 4.073M |
| Gossamer Bio, Inc. | 295.01M |
| Century Therapeutics, Inc. | 64.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.78M |
| Shareholders Equity (Quarterly) | 42.01M |
| Debt to Equity Ratio | 0.3652 |
| Current Ratio | 4.852 |
| Net Debt Paydown Yield | 1.91% |